Vega eliminates challenges associated with conventional handheld ultrasound systems, PerkinElmer said. The company gained the Vega technology with the acquisition of SonoVol.
The Vega ultrasound platform comes with two automated transducers and does not require a sonographer. Key features include brightness and motion modes, acoustic angiography mode for visualization of microvasculature, and shear wave elastography mode to measure and evaluate tissue stiffness.
Vega's widefield imaging enables researchers to visualize the pathophysiology of diseases such as cancer, liver and kidney disease, and cardio diseases, Perkin Elmer said.